US panel warns China tightening grip on drug supply chain, risking access to treatments
Published 1 d ago4 sourcesEvidence: Reported
Major pharmaceutical companies have notified a U.S. House committee of plans to suspend clinical trials at select hospitals in China. The move follows heightened congressional scrutiny of trial integrity and data security risks. The scope of hospitals and companies affected remains unclear, but the shift signals a broader de-risking of China-based clinical operations.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Locations
Entities
Published 1 d ago4 sourcesEvidence: Reported
Published 19 h ago7 sourcesEvidence: Reported
Published 21 h ago12 sourcesEvidence: Reported
Published 1 d ago10 sourcesEvidence: Reported
Published 2 d ago6 sourcesEvidence: Reported
Published 2 d ago8 sourcesEvidence: Reported
Published 1 d ago7 sourcesEvidence: Reported
Published 2 d ago13 sourcesEvidence: Reported